Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Plasma coenzyme Q10 status is impaired in selected genetic conditions

  • Montero, R.
  • Yubero, D.
  • Salgado, M.C.
  • González, M.J.
  • Campistol, J.
  • O''Callaghan, M.D.M.
  • Pineda, M.
  • Delgadillo, V.
  • Maynou, J.
  • Fernandez, G.
  • Montoya, J.
  • Ruiz-Pesini, E.
  • Meavilla, S.
  • Neergheen, V.
  • García-Cazorla, A.
  • Navas, P.
  • Hargreaves, I.
  • Artuch, R.
Identifying diseases displaying chronic low plasma Coenzyme Q10 (CoQ) values may be important to prevent possible cardiovascular dysfunction. The aim of this study was to retrospectively evaluate plasma CoQ concentrations in a large cohort of pediatric and young adult patients. We evaluated plasma CoQ values in 597 individuals (age range 1 month to 43 years, average 11 years), studied during the period 2005-2016. Patients were classified into 6 different groups: control group of healthy participants, phenylketonuric patients (PKU), patients with mucopolysaccharidoses (MPS), patients with other inborn errors of metabolism (IEM), patients with neurogenetic diseases, and individuals with neurological diseases with no genetic diagnosis. Plasma total CoQ was measured by reverse-phase high-performance liquid chromatography with electrochemical detection and ultraviolet detection at 275¿nm. ANOVA with Bonferroni correction showed that plasma CoQ values were significantly lower in the PKU and MPS groups than in controls and neurological patients. The IEM group showed intermediate values that were not significantly different from those of the controls. In PKU patients, the Chi-Square test showed a significant association between having low plasma CoQ values and being classic PKU patients. The percentage of neurogenetic and other neurological patients with low CoQ values was low (below 8%). In conclusión, plasma CoQ monitoring in selected groups of patients with different IEM (especially in PKU and MPS patients, but also in IEM under protein-restricted diets) seems advisable to prevent the possibility of a chronic blood CoQ suboptimal status in such groups of patients.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Muscle Involvement in a Large Cohort of Pediatric Patients with Genetic Diagnosis of Mitochondrial Disease

  • Jou, C.
  • Ortigoza-Escobar, J.D.
  • Ocallaghan, M.M.
  • Nascimento, A.
  • Darling, A.
  • Pias-Peleteiro, L.
  • Perez-Duenas, B.
  • Pineda, M.
  • Codina, A.
  • Arjona, C.
  • Armstrong, J.
  • Palau, F.
  • Ribes, A.
  • Gort, L.
  • Tort, F.
  • Navas, P.
  • Ruiz-Pesini, E.
  • Emperador, S.
  • Lopez-Gallardo, E.
  • Bayona-Bafaluy, P.
  • Montero, R.
  • Jimenez-Mallebrera, C.
  • Garcia-Cazorla, A.
  • Montoya, J.
  • Yubero, D.
  • Artuch, R.
Mitochondrial diseases (MD) are a group of genetic and acquired disorders which present significant diagnostic challenges. Here we report the disease characteristics of a large cohort of pediatric MD patients (n = 95) with a definitive genetic diagnosis, giving special emphasis on clinical muscle involvement, biochemical and histopathological features. Of the whole cohort, 51 patients harbored mutations in nuclear DNA (nDNA) genes and 44 patients had mutations in mitochondrial DNA (mtDNA) genes. The nDNA patients were more likely to have a reduction in muscle fiber succinate dehydrogenase (SDH) stains and in SDH-positive blood vessels, while a higher frequency of mtDNA patients had ragged red (RRF) and blue fibers. The presence of positive histopathological features was associated with ophthalmoplegia, myopathic facies, weakness and exercise intolerance. In 17 patients younger than two years of age, RRF and blue fibers were observed only in one case, six cases presented cytochrome c oxidase (COX) reduction/COX-fibers, SDH reduction was observed in five and all except one presented SDH-positive blood vessels. In conclusion, muscle involvement was a frequent finding in our series of MD patients, especially in those harboring mutations in mtDNA genes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Muscle involvement in a large cohort of pediatric patients with genetic diagnosis of mitochondrial disease

  • Jou, C.
  • Ortigoza-Escobar, J.D.
  • O'Callaghan, M.M.
  • Nascimento, A.
  • Darling, A.
  • Pias-Peleteiro, L.
  • Perez-Duenas, B.
  • Pineda, M.
  • Codina, A.
  • Arjona, C.
  • Armstrong, J.
  • Palau, F.
  • Ribes, A.
  • Gort, L.
  • Tort, F.
  • Navas, P.
  • Ruiz-Pesini, E.
  • Emperador, S.
  • Lopez-Gallardo, E.
  • Bayona-Bafaluy, P.
  • Montero, R.
  • Jimenez-Mallebrera, C.
  • Garcia-Cazorla, A.
  • Montoya, J.
  • Yubero, D.
  • Artuch, R.
P06.32C Mitochondrial diseases (MD) are a group of genetic and acquired disorders which present significant diagnostic challenges. Here we report the disease characteristics of a large cohort of pediatric MD patients (n = 95) with a definitive genetic diagnosis, giving special emphasis on clinical muscle involvement, biochemical and histopathological features. Of the whole cohort, 51 patients harbored mutations in nuclear DNA (nDNA) genes and 44 patients had mutations in mitochondrial DNA (mtDNA) genes. The nDNA patients were more likely to have a reduction in muscle fiber succinate dehydrogenase (SDH) stains and in SDH-positive blood vessels, while a higher frequency of mtDNA patients had ragged red (RRF) and blue fibers. The presence of positive histopathological features was associated with ophthalmoplegia, myopathic facies, weakness and exercise intolerance. In 17 patients younger than two years of age, RRF and blue fibers were observed only in one case, six cases presented cytochrome c oxidase (COX) reduction/COX-fibers, SDH reduction was observed in five and all except one presented SDH-positive blood vessels. In conclusion, muscle involvement was a frequent finding in our series of MD patients, especially in those harboring mutations in mtDNA genes.